Medical Oncologist
CION Cancer Clinics
Chemotherapy before and after upper tract surgery | CION Cancer Clinics
Chemotherapy is sometimes given before or after surgery for upper tract urothelial cancer, the cancer of the kidney lining and ureter. After surgery, it is mainly offered when the report shows deep growth into the wall or cancer in lymph nodes. Before surgery, it is considered because both kidneys still work, which allows stronger medicines. This page explains both timings, who they do not suit, and what to ask. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Will you need chemotherapy before or after this surgery?
- How do the two timings compare?
- Which treatments may be discussed?
- How does the plan usually unfold?
- Which words on the report shape this decision?
- Four things families tell us, and what is actually true
- Who is it not suited to, and what can this page not tell you?
- Common questions about chemotherapy around upper tract surgery
The short answer
Will you need chemotherapy before or after this surgery?
Not everyone does. Chemotherapy around a nephroureterectomy is aimed at people whose tumour is more likely to return, usually because it has grown deep into the wall or reached the lymph nodes. For a tumour on the surface of the lining, surgery and regular checks are usually the plan.
Chemotherapy after surgery
This is called adjuvant chemotherapy, meaning extra treatment after the operation to lower the chance of the cancer returning. The decision rests on the pathology report, the examination of the removed kidney and ureter under a microscope, which shows how deep the tumour went. A large UK trial found that for tumours that had grown deeper, chemotherapy after surgery lowered the chance of the cancer returning compared with watching alone.
Chemotherapy before surgery
This is called neoadjuvant chemotherapy. The main argument for it is the kidneys. Before the operation you have two, and afterwards you have one, so some people who could have the stronger medicine beforehand no longer can after. The difficulty is that before surgery nobody knows for certain how deep the tumour has grown, because a telescope biopsy is small. The evidence for this approach so far comes from smaller studies.
Whether chemotherapy is given, and when, is decided by your tumour board and oncologist. This page explains what they weigh.Side by side
How do the two timings compare?
Before surgery (neoadjuvant)
After surgery (adjuvant)
Given while both kidneys still work
Given when only one kidney remains
Decided on biopsy and scans, which can underestimate the tumour
Decided on the full report, which shows the true depth
Can shrink the tumour before the operation
Aims at cancer cells that may remain afterwards
Moves the operation later by the length of the course
Starts once you have recovered from the operation
Evidence mainly from smaller studies
Supported by a large randomised trial
Not sure whether this applies to you?
Ask an oncologistWhat you may hear
Which treatments may be discussed?
Your oncologist chooses on your kidney function, your fitness and your report. These are the names you are most likely to hear.
Cisplatin-based chemotherapy
Cisplatin, usually paired with gemcitabine, is the standard combination for this type of cancer. It is given as a drip in day-care over a course of cycles.
It needs reasonably good
- Kidney function
- Hearing
- Heart strength and general fitness
Carboplatin-based chemotherapy
Carboplatin with gemcitabine is often used when kidney function is too low for cisplatin. It is gentler on the kidneys, though it tends to lower blood counts more.
Immunotherapy after surgery
For some people with a high-risk report, an immunotherapy drip after surgery may be discussed, particularly when chemotherapy is not suitable. Whether it suits you depends on the report and your other conditions.
A single dose into the bladder
Separate from all the above, a single dose of chemotherapy is often placed into the bladder through the catheter around the time of surgery. It lowers the chance of a bladder tumour, and it does not treat the rest of the body.
The pathway
How does the plan usually unfold?
-
Diagnosis and staging
A CT urogram, a telescope biopsy, and scans of the chest and belly. Blood tests include kidney function, and sometimes a scan shows how much work each kidney does.
-
Tumour board
Surgical, medical and radiation oncologists review your case together. They weigh how deep the tumour is likely to be, how well your kidneys work and how fit you are.
-
If chemotherapy comes first
A course of cycles in day-care, with blood tests before each one. A scan afterwards checks the response, and surgery follows once your blood counts have recovered.
-
The operation
The kidney, the whole ureter and a cuff of bladder are removed. The tissue goes to the pathology laboratory.
-
The report and the second decision
The pathology report shows depth, grade, margins and lymph nodes. If chemotherapy was not given before surgery, this is when treatment afterwards is discussed.
-
If chemotherapy comes after
It starts once you have recovered well from the operation, meaning the wound has healed and you are eating and walking. Your kidney function at that point decides which medicine is used.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
Which words on the report shape this decision?
- pT stage
- How deep the tumour grew in the removed tissue. Ta and T1 are on or just under the surface. T2 and higher mean deeper growth.
- N stage
- Whether cancer was found in the lymph nodes. N0 means none was found.
- Grade
- How abnormal the cells look. High-grade tumours tend to grow faster.
- Margin
- The edge of the removed tissue. A positive margin means cancer cells reached that edge.
- eGFR
- An estimate of how well the kidneys filter, from a blood test. It often decides between cisplatin and carboplatin.
- Cycle
- One round of chemotherapy followed by a rest period, repeated through the course.
Commonly believed
Four things families tell us, and what is actually true
"If the surgeon removed everything, chemotherapy is pointless."
Surgery removes what can be seen. When a tumour has grown deep or reached lymph nodes, cancer cells too small to see may already be elsewhere. Chemotherapy afterwards is aimed at those cells. It is offered because of the report, not because the operation was incomplete.
"Chemotherapy before surgery just delays the real treatment."
It is real treatment in its own right, given while the kidneys are at their strongest. The course is planned so that surgery follows once you have recovered. It does not suit everyone, and your team should explain why it is or is not being suggested.
"Chemotherapy will destroy the kidney he has left."
Some medicines can strain the kidney. That is exactly why kidney function is tested before every cycle and the medicine is chosen to match it. If the numbers drop, the plan is changed.
"Stronger chemotherapy is always the better choice."
The right medicine is the one your body can take safely. A gentler combination given in full can serve you better than a stronger one stopped early because of side effects.
Being straight with you
Who is it not suited to, and what can this page not tell you?
Chemotherapy around this surgery is usually not recommended when the tumour is low grade and on the surface of the lining, because the benefit is small and the side effects are real. Cisplatin in particular does not suit people with low kidney function, marked hearing loss, heart failure, or numbness and tingling in the hands and feet already. People who are very frail may be offered close follow-up instead.
Questions worth asking your team
Is chemotherapy being suggested before surgery, after it, or not at all, and why? What is my kidney function now, and what is it likely to be after the operation? Which medicines would be used, over how long, and where would I have them? Which side effects should make me call?
What this page cannot tell you
It cannot tell you whether chemotherapy will be offered to you, or what difference it would make in your case. That depends on your own report, your kidneys and your fitness. It is a decision your treating team makes with you, and you are entitled to have the reasons explained.
Questions we are asked
Common questions about chemotherapy around upper tract surgery
How long does chemotherapy around this surgery take?
A course usually runs over a few months, as a set of cycles with rest periods in between. You come to day-care for each drip and go home the same day. Your oncologist will tell you how many cycles are planned and the dates, so the family can arrange time and travel.
Will I lose my hair?
It depends on the medicines. With gemcitabine combinations, many people notice thinning rather than complete hair loss, though this varies. Tiredness, feeling sick and low blood counts are usually the bigger concerns. Your team will explain the likely effects of your own combination before the first cycle.
Can the chemotherapy be given closer to home?
Often yes, if the centre gives this chemotherapy, checks blood tests before each cycle, and shares reports with your surgical team. Travelling from a district for every cycle can be tiring, so ask your oncologist early whether part of the course can be given nearer to where you live.
What if my kidney function is too low for chemotherapy?
There are still options. Carboplatin may be used in place of cisplatin, or immunotherapy after surgery may be discussed for a high-risk report. For some people, close follow-up with scans is the plan. A low eGFR changes the choice of treatment. It does not mean your team stops looking after you.
Why was chemotherapy offered to my father but not to our neighbour?
Because the decision rests on each person's report and health. Two people with the same operation can have very different tumour depth, grade, lymph node findings and kidney function. Comparing plans between patients usually causes more worry than it settles. Ask your own team to explain the reasons in your case.
When does chemotherapy start after the operation?
Once you have recovered enough: the wound has healed, you are eating and walking, and your blood tests are stable. Your oncologist sets the timing. A slower recovery is common and is planned around. Tell your team if recovery is taking longer than you expected.
Which side effects mean I should call straight away?
A fever or shivering during chemotherapy needs attention the same day, because blood counts can be low. So do bleeding, vomiting that stops you keeping fluids down, passing very little urine, or breathlessness. Your team will give you a number to call and written advice before the first cycle.
Is chemotherapy covered by Aarogyasri or insurance?
Chemotherapy for cancer is often covered when it is part of an approved treatment plan. Aarogyasri, CGHS, ECHS and EHS are accepted, and most cashless insurers are empanelled. Call the helpline with your card or policy details and we will help you check your cover for the treatment planned.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ) - Patient Version
- American Cancer Society — Chemotherapy for bladder cancer
- Cancer Research UK — Chemotherapy
- Cancer.Net — Bladder cancer
- Macmillan Cancer Support — Bladder cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Chemotherapy guideDay-care, cycles and side effects in more depthKidney Function After NephroureterectomyWhy one kidney changes the medicine choiceUpper Tract Urothelial Cancer ExplainedThe cancer this treatment is forThe Pathology Report After SurgeryThe report that decides treatment after surgeryImmunotherapy guideThe option sometimes discussed when chemotherapy does not suit
Talk to us
Been told chemotherapy may be part of the plan?
Send us the biopsy, scan or pathology reports, or call the helpline. We will help you understand what is being suggested and reach the right specialist. One helpline serves every CION centre.